ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
for Breast Cancer, Metastatic
21 locations incl. Tucson
Sponsor: ALX Oncology Inc.
Sex: All·Age: 18+
Code: NCT07007559·Phase 2·Recruiting·Listed Jun 2025